SEC Comment Letter 0000000000-24-007151 to CARGO Therapeutics, Inc. (CRGX) (CIK 0001966494)
CARGO Therapeutics, Inc. (CRGX) (CIK 0001966494)
Date: June 25, 2024 · CIK: 0001966494 · Accession: 0000000000-24-007151
AI Filing Summary & Sentiment
File numbers found in text: 333-280249
Letter
United States securities and exchange commission logo June 25, 2024 Gina Chapman Chief Executive Officer CARGO Therapeutics, Inc. 835 Industrial Road, Suite 400 San Carlos, CA 94070 Re:CARGO Therapeutics, Inc. Registration Statement on Form S-1 Filed June 17, 2024 File No. 333-280249 Dear Gina Chapman: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jessica Dickerson at 202-551-8013 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Phillip S. Stoup, Esq.
Show Raw Text
United States securities and exchange commission logo
June 25, 2024
Gina Chapman
Chief Executive Officer
CARGO Therapeutics, Inc.
835 Industrial Road, Suite 400
San Carlos, CA 94070
Re:CARGO Therapeutics, Inc.
Registration Statement on Form S-1
Filed June 17, 2024
File No. 333-280249
Dear Gina Chapman:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jessica Dickerson at 202-551-8013 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Phillip S. Stoup, Esq.